Vulnerability · CVE-2025-43805
Liferay Portal 7.3.0 through 7.4.3.111, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, and 7.3 GA through update 35 does not perform an authoriza
Published Sep 16, 2025 · catalog updated Sep 17, 2025 · Liferay DXP
Last checked Oct 29, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2025-43805. EPSS is 0.29%. Act only if a listed version of Liferay DXP is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
Same product and reporting
- CVE-2025-62275 · Medium
- CVE-2025-62276 · Medium
- CVE-2025-62267 · Medium
- CVE-2025-62264 · Medium
- CVE-2025-62265 · Medium
- Severity
- Medium6.9
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.29%
- Remediation
- Advisory link
- Affected products
- vendor Liferay DXP 2023.Q3.1 ≤2023.Q3.4
Liferay Portal 7.3.0 through 7.4.3.111, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, and 7.3 GA through update 35 does not perform an authorization check when users attempt to view a display page template, which allows remote attackers to view display page templates via crafted URLs.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor Liferay DXP 2023.Q3.1 ≤2023.Q3.42023.Q3.1 ≤2023.Q3.4
How to fix CVE-2025-43805
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in 2023.Q3.1 ≤2023.Q3.4
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-43805. EPSS is 0.29%. Act only if a listed version of Liferay DXP is installed.
Which versions are affected?
Compare what you have installed with Liferay DXP 2023.Q3.1 ≤2023.Q3.4 2023.Q3.1 ≤2023.Q3.4. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.29%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Sep 16, 2025 · EUVD
Detected
Liferay Portal 7.3.0 through 7.4.3.111, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, and 7.3 GA through update 35 does not perform an authorization check when users attempt to view a display page template, which allows remote attackers to view display page templates via crafted URLs.
Sep 17, 2025 · EUVD
Updated
Liferay Portal 7.3.0 through 7.4.3.111, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, and 7.3 GA through update 35 does not perform an authorization check when users attempt to view a display page template, which allows remote attackers to view display page templates via crafted URLs.
Sources
- CVE.orgVulnerability recordCVE-2025-43805
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-43805
30-day exploitation probability 0.29%
first.org - EUVDVulnerability recordEUVD-2025-29658
Liferay Portal 7.3.0 through 7.4.3.111, and Liferay DXP 2023.Q4.0, 2023.Q3.1 through 2023.Q3.4, 7.4 GA through update 92, and 7.3 GA through update 35 does not perform an authorization check when users attempt to view a display page template, which allows remote attackers to view
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 29, 2026
- CVE.orgOct 23, 2026
- EUVDOct 23, 2026